BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 33968409)

  • 1. Autoantibodies against complement component C1q in systemic lupus erythematosus.
    Trendelenburg M
    Clin Transl Immunology; 2021; 10(4):e1279. PubMed ID: 33968409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies against C1q in patients with systemic lupus erythematosus.
    Trendelenburg M
    Springer Semin Immunopathol; 2005 Nov; 27(3):276-85. PubMed ID: 16189648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways.
    Thanei S; Vanhecke D; Trendelenburg M
    Clin Immunol; 2015 Oct; 160(2):180-7. PubMed ID: 26148903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus.
    Holers VM
    J Clin Invest; 2004 Sep; 114(5):616-9. PubMed ID: 15343378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies to the collagen-like region of C1q are strongly associated with classical pathway-mediated hypocomplementemia in systemic lupus erythematosus.
    Frémeaux-Bacchi V; Weiss L; Demouchy C; Blouin J; Kazatchkine MD
    Lupus; 1996 Jun; 5(3):216-20. PubMed ID: 8803893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C1q, autoimmunity and apoptosis.
    Botto M; Walport MJ
    Immunobiology; 2002 Sep; 205(4-5):395-406. PubMed ID: 12396002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement and systemic lupus erythematosus.
    Walport MJ
    Arthritis Res; 2002; 4 Suppl 3(Suppl 3):S279-93. PubMed ID: 12110148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C1q and systemic lupus erythematosus.
    Walport MJ; Davies KA; Botto M
    Immunobiology; 1998 Aug; 199(2):265-85. PubMed ID: 9777411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-C1q Antibodies as Occurring in Systemic Lupus Erythematosus Could Be Induced by an Epstein-Barr Virus-Derived Antigenic Site.
    Csorba K; Schirmbeck LA; Tuncer E; Ribi C; Roux-Lombard P; Chizzolini C; Huynh-Do U; Vanhecke D; Trendelenburg M
    Front Immunol; 2019; 10():2619. PubMed ID: 31787984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus.
    Seelen MA; Trouw LA; Daha MR
    Curr Opin Nephrol Hypertens; 2003 Nov; 12(6):619-24. PubMed ID: 14564199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-C1q autoantibodies from patients with systemic lupus erythematosus induce C1q production by macrophages.
    Thanei S; Trendelenburg M
    J Leukoc Biol; 2017 Feb; 101(2):481-491. PubMed ID: 27630215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary C1q deficiency and systemic lupus erythematosus.
    Bowness P; Davies KA; Norsworthy PJ; Athanassiou P; Taylor-Wiedeman J; Borysiewicz LK; Meyer PA; Walport MJ
    QJM; 1994 Aug; 87(8):455-64. PubMed ID: 7922299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autoantibodies against the complement component C1q in systemic lupus erythematosus].
    Antes U; Heinz HP; Hartung K; Loos M
    Klin Wochenschr; 1990 Nov; 68(21):1066-70. PubMed ID: 2084321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-C1q in systemic lupus erythematosus.
    Stojan G; Petri M
    Lupus; 2016 Jul; 25(8):873-7. PubMed ID: 27252264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay.
    Vanhecke D; Roumenina LT; Wan H; Osthoff M; Schaller M; Trendelenburg M
    Arthritis Rheum; 2012 Nov; 64(11):3706-14. PubMed ID: 22740328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High occurrence of in vitro apoptosis of lymphocytes induced by serum from systemic lupus erythematosus patients is associated with increased serum levels of anti-C1q autoantibodies.
    Hasan SI; Mohd Ashari NS; Mohd Daud K; Che Husin CM
    Int J Rheum Dis; 2013 Aug; 16(4):430-6. PubMed ID: 23992264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosus.
    Magro-Checa C; Schaarenburg RA; Beaart HJ; Huizinga TW; Steup-Beekman GM; Trouw LA
    Lupus; 2016 Jul; 25(8):878-88. PubMed ID: 27252265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q.
    Mok CC; Birmingham DJ; Ho LY; Hebert LA; Song H; Rovin BH
    Lupus; 2012 Jan; 21(1):36-42. PubMed ID: 21993384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies against mannose-binding lectin in systemic lupus erythematosus.
    Seelen MA; Trouw LA; van der Hoorn JW; Fallaux-van den Houten FC; Huizinga TW; Daha MR; Roos A
    Clin Exp Immunol; 2003 Nov; 134(2):335-43. PubMed ID: 14616796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.